21/05/2026
OUR NEUROFIBROMATOSIS STORY
A Story of Missed Chances, Parental Instinct, and Fighting for Our child.
When your child is diagnosed with Neurofibromatosis type 1 (NF1), your world changes in ways you never expect. Suddenly every appointment, every symptom, every instinct matters — and you learn very quickly that as a parent, you sometimes have to be louder than you ever wanted to be.
Our journey with NF1 began years before we knew what it was.
In 2010, my partner Christopher (Chris), who was serving in the Royal Air Force at the time, was assaulted on a night out and sustained a head injury. During routine scans in hospital, doctors unexpectedly discovered three brain tumours — pilocytic astrocytomas. A VP shunt was inserted, and Chris was told this was now something he would live with. Later, after being medically discharged from the RAF and moving into NHS Greater Glasgow care, we were told the shunt should never have been placed — but by then his body had adapted and it could not be removed.
At the time, no one mentioned NF1.
Years later, in 2014, Chris and I met while studying adult nursing at the University of Dundee. When our relationship became serious, he explained his medical history — the tumours, the shunt — and that was that. Like many families, we didn’t yet realise there was a bigger picture.
In 2017, everything changed.
One morning, my eldest daughter found Chris unresponsive in bed. He was rushed by blue light to Ninewells Hospital, where we learned his VP shunt had completely blocked. Emergency surgery saved his life, but this was followed by further blockages and repeated neurosurgical care.
During this time, I began to notice physical signs — large café au lait patches, freckling in his groin and armpits — and as a parent who had already faced health challenges with two other children, something didn’t feel right.
I asked a neurosurgeon whether Chris could have NF1.
I was dismissed. I was told it wasn’t genetic. I was told not to worry.
We wanted a child together, and I needed reassurance. I didn’t get it.
Months later, we learned we were expecting our daughter, Anaya. She was born in January 2019 — perfect, we thought. But by six weeks old, I noticed multiple café au lait marks covering her tiny back. Because of what I’d already seen in her dad, alarm bells rang immediately.
This time, I didn’t wait.
Within weeks, both Anaya and Chris were seen by genetics at Victoria Hospital in Kirkcaldy. Based on appearance alone, they were informally diagnosed with NF1. Blood tests later confirmed it — both carried the NF1 gene.
As a parent, you expect that once you have a diagnosis, care will naturally follow. That wasn’t our experience.
Anaya’s early care felt fragmented. NF1 wasn’t well understood locally, and important checks were missed.
It wasn’t until we were connected with Tumour Support Scotland that everything changed.
Through them, we accessed a specialist NF1 clinic in Edinburgh — and at Anaya’s first appointment, they identified dangerously high blood pressure. Something that should be routinely checked in children with NF1, yet never once had been.
Further investigations showed plexiform tumours around her kidneys, causing the hypertension. Medication was started — something that could have been missed entirely without specialist input.
Despite my growing concerns, I was told Anaya didn’t qualify for an MRI “just because she had NF1.” But instincts matter. With persistence — and the backing of Tumour Support Scotland — Anaya finally had her first MRI. It showed Unidentified Bright Objects (UBOs), common in NF1, but in her case, they were the earliest signs of tumours forming.
In December 2020, we heard the words no parent wants to hear.
Two brain tumours. One on her optic nerve.
Without immediate chemotherapy, Anaya would lose her sight.
The next 20 months were unimaginably hard. Chemotherapy. Long hospital stays. Serious reactions to carboplatin. Repeated admissions. At some point during treatment, a third brain tumour appeared. All while trying to give a child a normal life where possible.
In August 2023, Anaya completed chemotherapy. At the same time, her dad attended a routine MRI. In September 2023 — on the same day — we sat in two different hospitals, minutes apart, being told devastating news about both of them. Anaya’s scans were stable. Chris’s tumour had grown. He needed radiotherapy immediately.
Chris completed six weeks of radiotherapy in October 2023. For a brief moment, there was hope — but by August 2024, scans showed further progression. Chemotherapy tablets followed. The most recent MRI showed the tumour has doubled in size and spread.
Right now, all that can be done is manage his condition.
NF1 has reshaped every part of our lives.
It’s impacted our mental health, our finances, our family relationships. Watching your child endure treatment to save their sight — while watching the person you love slowly change due to tumour growth — leaves marks that never fully fade.
There is no cure for NF1. Only management. Only vigilance.
We were handed leaflets and sent home on diagnosis day. If my father hadn’t happened to see the “Funny Lumps” car that day, if Tumour Support Scotland hadn’t stepped in, I don’t know where we would be. I don’t want to imagine it.
NF1 affects 1 in 3,000 people, yet support is inconsistent, and access to specialist care feels like a postcode lottery. Our story involves two people with NF1 — but the ripple effect has touched at least ten others in our family through lost work, emotional strain, and constant worry.
This story is still unfolding. My partner’s future is uncertain. My children’s futures are uncertain. And every parent living with NF1 understands that fear.
But we also understand this: early diagnosis, specialist care, and being listened to saves lives, saves sight, and saves families.
If sharing our story helps just one parent trust their instincts, push for answers, or find support — then it matters.